In the US, software startups attracted $121.2 billion in venture capital investments last year, more than triple what those in commercial products and services received, at $39.1 billion. Pharmaceuticals and biotech raised the third-highest amount, with $37.8 billion in venture capital.

Pharmaceutical Visits Went Virtual, Too. When patients and providers went virtual in the early days of the pandemic, so did pharmaceutical sales reps. Gone were the days of rolling suitcases full of samples into doctors’ offices or sponsoring fancy dinners or conferences to tell doctors about new drugs and treatments.

The pandemic spurred growth in India’s telemedicine market, per a September 2020 report from EY and Indian Pharmaceutical Alliance (IPA), and that sector is expected to keep expanding over the next few years. COVID-19 also led to a rise in online education.

Pharmaceutical companies are presented with the most organic opportunity to integrate with DTx, and these tie-ups come in multiple forms. For example, drugmakers can strike deals with DTx firms to gather patient data that helps inform new treatment development.

What opportunities is the technology creating for hospitals, healthcare payers, and pharmaceutical companies? WHAT’S IN THIS REPORT? This report presents our user forecast for remote patient monitoring (RPM) through 2025, key trends driving adoption, and implications for the rapidly growing market.

Sey had received specific instructions from Levi’s human resources department in late 2021 about topics she should avoid commenting on publicly, such as the California governor recall election, vaccine regulations, and pharmaceutical company motives.

Pharmaceutical companies are also vulnerable. Cybercriminals have targeted pharma and biotech firms to gain access to COVID-19 research and vaccine development data, according to Reposify’s 2021 report titled “Pharmaceutical Industry: The State of the External Attack Surface.” Some 92% of pharmaceutical companies had at least one exposed database with potential data leakage, the report noted.

Healthcare and pharma: Includes pharmaceutical products, facilities, services, researchers, drug manufacturers and marketers, doctors, hospitals, and biological products, as well as establishments providing healthcare services and social assistance for individuals; also includes health insurance.